{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:10:07Z","timestamp":1790961007356,"version":"4.1.0"},"reference-count":67,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathophysiology"],"abstract":"<jats:p>Multiple sclerosis (MS) is a chronic, immune-mediated demyelinating disease of the central nervous system whose heterogeneous clinical, radiological, and biological course has long resisted precise individual-level prediction. The recent convergence of large longitudinal datasets, advanced computational methods, and increasingly informative biomarkers has created conditions in which artificial intelligence (AI) and machine learning (ML) can begin to address that problem substantively. This review surveys the current evidence for AI\/ML applications across the MS care continuum, with particular focus on the literature from 2022 through early 2026. Nine domains are examined: automated MRI lesion segmentation and quantification, fluid biomarker interpretation, unsupervised disease subtyping, disability progression prediction, treatment response stratification, drug repurposing and molecular discovery, digital biomarker monitoring, mechanistic interpretability, and integrated clinical management protocols. Notable recent contributions include the SuStaIn-based identification of two biologically distinct MS trajectories distinguished by early versus late serum neurofilament light chain elevation, the MindGlide deep learning platform enabling longitudinal analysis of archived routine clinical MRI data, the T-cell morphological classifier predicting natalizumab treatment response before drug initiation, and the fenebrutinib Phase III program that produced the first Bruton\u2019s tyrosine kinase inhibitor results meeting primary endpoints in both relapsing and primary progressive MS. A proposed AI-Enhanced Management Protocol (AMP-26) reflecting 2026 clinical standards is included as an appendix. Throughout, emphasis is placed on mechanistic interpretability: the distinction between models that correlate features with outcomes and models whose decision logic reflects established MS pathobiology is considered a prerequisite for clinical credibility and regulatory readiness.<\/jats:p>","DOI":"10.3390\/pathophysiology33020035","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:31:56Z","timestamp":1779885116000},"page":"35","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanistic Insights into the Role of Artificial Intelligence and Machine Learning in the Diagnosis and Management of Multiple Sclerosis"],"prefix":"10.3390","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4194-8104","authenticated-orcid":false,"given":"Alireza","family":"Minagar","sequence":"first","affiliation":[{"name":"Multiple Sclerosis Research Center, Neuroscience Institute, Sina Hospital, Hassan Abad Square, Imam Khomeini Street, Tehran 1136746911, Iran"},{"name":"School of Cybersecurity and Information Technology, University of Maryland Global Campus, Adelphi, MD 20783, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadali","family":"Sahraian","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Research Center, Neuroscience Institute, Sina Hospital, Hassan Abad Square, Imam Khomeini Street, Tehran 1136746911, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1038\/s41591-025-03901-6","article-title":"AI-driven reclassification of multiple sclerosis progression","volume":"31","author":"Ganjgahi","year":"2025","journal-title":"Nat. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1093\/brain\/awaf331","article-title":"Combined magnetic resonance imaging and serum analysis reveals distinct multiple sclerosis types","volume":"148","author":"Willard","year":"2025","journal-title":"Brain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: The 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11910-024-01354-x","article-title":"Artificial intelligence and multiple sclerosis","volume":"24","author":"Amin","year":"2024","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1007\/s00415-024-12651-3","article-title":"Predicting multiple sclerosis disease progression and outcomes with machine learning and MRI-based biomarkers: A review","volume":"271","author":"Yousef","year":"2024","journal-title":"J. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Praet, J., Anderhalten, L., Comi, G., Horakova, D., Ziemssen, T., Vermersch, P., Lukas, C., van Leemput, K., Steppe, M., and Aguilera, C. (2024). A future of AI-driven personalized care for people with multiple sclerosis. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1446748"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/13524585251327300","article-title":"AI-assisted identification of disability patterns within identical EDSS grades","volume":"31","author":"Greselin","year":"2025","journal-title":"Mult. Scler."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e209444","DOI":"10.1212\/WNL.0000000000209444","article-title":"Using the progression independent of relapse activity framework to unveil the pathobiological foundations of multiple sclerosis","volume":"103","author":"Ciccarelli","year":"2024","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamaneurol.2023.3331","article-title":"Harmonizing definitions for progression independent of relapse activity in multiple sclerosis: A systematic review","volume":"80","author":"Cagol","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3892\/etm.2021.10583","article-title":"Emerging deep learning techniques using magnetic resonance imaging data applied in multiple sclerosis and clinical isolated syndrome patients (Review)","volume":"22","author":"Kontopodis","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Rathmann, E., Hemkemeier, P., Raths, S., Grothe, M., Mankertz, F., Hosten, N., and Flessa, S. (2024). Changes in MRI workflow of multiple sclerosis after introduction of an AI-software: A qualitative study. Healthcare, 12.","DOI":"10.3390\/healthcare12100978"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41433-024-02933-5","article-title":"Diagnosis of multiple sclerosis using optical coherence tomography supported by explainable artificial intelligence","volume":"38","author":"Ortiz","year":"2024","journal-title":"Eye"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1177\/13524585241256540","article-title":"Cognitive progression independent of relapse in multiple sclerosis","volume":"30","author":"Fuchs","year":"2024","journal-title":"Mult. Scler."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1093\/brain\/awae013","article-title":"Imaging chronic active lesions in multiple sclerosis: A consensus statement","volume":"147","author":"Bagnato","year":"2024","journal-title":"Brain"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"102796","DOI":"10.1016\/j.nicl.2021.102796","article-title":"Fully automated detection of paramagnetic rims in multiple sclerosis lesions on 3T susceptibility-based MR imaging","volume":"32","author":"Lou","year":"2021","journal-title":"Neuroimage Clin."},{"key":"ref_19","unstructured":"Zvuloni, E., Celi, L.A., and Behar, J.A. (2023). Generalization in medical AI: A perspective on developing scalable models. arXiv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"21038","DOI":"10.1038\/s41598-020-78212-6","article-title":"Prediction of disease progression and outcomes in multiple sclerosis with machine learning","volume":"10","author":"Pinto","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103611","DOI":"10.1016\/j.nicl.2024.103611","article-title":"LST-AI: A deep learning ensemble for accurate MS lesion segmentation","volume":"42","author":"Wiltgen","year":"2024","journal-title":"Neuroimage Clin."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1038\/s41467-025-58274-8","article-title":"Enabling new insights from old scans by repurposing clinical MRI archives for multiple sclerosis research","volume":"16","author":"Goebl","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e70417","DOI":"10.1111\/ene.70417","article-title":"Machine learning analysis applied to prediction of early progression independent of relapse activity in multiple sclerosis patients","volume":"32","author":"Poretto","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1038\/s41467-025-60224-3","article-title":"In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis","volume":"16","author":"Chaves","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1177\/13524585241277376","article-title":"Integrating large language models in care, research, and education in multiple sclerosis management","volume":"30","author":"Inojosa","year":"2024","journal-title":"Mult. Scler."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s42466-023-00270-8","article-title":"Can ChatGPT explain it? Use of artificial intelligence in multiple sclerosis communication","volume":"5","author":"Inojosa","year":"2023","journal-title":"Neurol. Res. Pract."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"102872","DOI":"10.1016\/j.artmed.2024.102872","article-title":"Improving multiple sclerosis lesion segmentation across clinical sites: A federated learning approach with noise-resilient training","volume":"152","author":"Bai","year":"2024","journal-title":"Artif. Intell. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Hinostroza Fuentes, V.G., Karim, H.A., Tan, M.J.T., and AlDahoul, N. (2025). AI with agency: A vision for adaptive, efficient, and ethical healthcare. Front. Digit. Health, 7.","DOI":"10.3389\/fdgth.2025.1600216"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s42484-024-00171-2","article-title":"Evaluation of VQC-LSTM for disability forecasting in multiple sclerosis using sequential multisequence MRI","volume":"6","author":"Mayfield","year":"2024","journal-title":"Quantum Mach. Intell."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ashtari, P., Barile, B., Van Huffel, S., and Sappey-Marinier, D. (2022). New multiple sclerosis lesion segmentation and detection using pre-activation U-Net. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.975862"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41746-023-00940-6","article-title":"A real-world clinical validation for AI-based MRI monitoring in multiple sclerosis","volume":"6","author":"Barnett","year":"2023","journal-title":"npj Digit. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"111638","DOI":"10.1016\/j.ejrad.2024.111638","article-title":"AI supported detection of cerebral multiple sclerosis lesions decreases radiologic reporting times","volume":"178","author":"Peters","year":"2024","journal-title":"Eur. J. Radiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1007\/s00330-022-08610-z","article-title":"Stratification of multiple sclerosis patients using unsupervised machine learning: A single-visit MRI-driven approach","volume":"32","author":"Pontillo","year":"2022","journal-title":"Eur. Radiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: A retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaneurol.2022.5250","article-title":"Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis","volume":"80","author":"Meier","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Healy, B.C., Rotstein, D., Guttmann, C.R., Bakshi, R., Weiner, H.L., Brodley, C.E., and Chitnis, T. (2017). Exploration of machine learning techniques in predicting multiple sclerosis disease course. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0174866"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"101593","DOI":"10.1016\/j.nicl.2018.11.003","article-title":"Predicting conversion from clinically isolated syndrome to multiple sclerosis: An imaging-based machine learning approach","volume":"21","author":"Zhang","year":"2019","journal-title":"NeuroImage Clin."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"De Brouwer, E., Arany, A., Simm, J., and Moreau, Y. (2024). Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study. PLoS Digit. Health, 3.","DOI":"10.1371\/journal.pdig.0000533"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"fcae427","DOI":"10.1093\/braincomms\/fcae427","article-title":"Machine learning-based prediction of disease progression in primary progressive multiple sclerosis","volume":"7","author":"Gurevich","year":"2025","journal-title":"Brain Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/RLI.0000000000000854","article-title":"A deep learning approach to predicting disease progression in multiple sclerosis using magnetic resonance imaging","volume":"57","author":"Storelli","year":"2022","journal-title":"Investig. Radiol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Campanioni, S., Veiga, C., Prieto-Gonz\u00e1lez, J.M., Gonz\u00e1lez-N\u00f3voa, J.A., Busto, L., Martinez, C., Alberte-Woodward, M., Garc\u00eda de Soto, J., Pouso-Diz, J., and Fern\u00e1ndez Ceballos, M.L.\u00c1. (2024). Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0306999"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"104970","DOI":"10.1016\/j.ebiom.2024.104970","article-title":"Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management","volume":"101","author":"Freedman","year":"2024","journal-title":"EBioMedicine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"11795735241249693","DOI":"10.1177\/11795735241249693","article-title":"From progression to progress: The future of multiple sclerosis","volume":"16","author":"Oh","year":"2024","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Werthen-Brabants, L., Dhaene, T., and Deschrijver, D. (2025). The role of trustworthy and reliable AI for multiple sclerosis. Front. Digit. Health, 7.","DOI":"10.3389\/fdgth.2025.1507159"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","article-title":"Regenerating CNS myelin\u2014From mechanisms to experimental medicines","volume":"18","author":"Franklin","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"578315","DOI":"10.1016\/j.jneuroim.2024.578315","article-title":"Recent advances in the treatment of primary and secondary progressive multiple sclerosis","volume":"390","author":"Sriwastava","year":"2024","journal-title":"J. Neuroimmunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41467-021-21770-8","article-title":"Identification of disease treatment mechanisms through the multiscale interactome","volume":"12","author":"Ruiz","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"112505","DOI":"10.1016\/j.exger.2024.112505","article-title":"Identification of novel drug targets for multiple sclerosis by integrating plasma genetics and proteomes","volume":"194","author":"Liu","year":"2024","journal-title":"Exp. Gerontol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Li, W., Ma, W., Yang, M., and Tang, X. (2024). Drug repurposing based on the DTD-GNN graph neural network: Revealing the relationships among drugs, targets and diseases. BMC Genom., 25.","DOI":"10.1186\/s12864-024-10499-5"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1016\/j.cell.2024.11.015","article-title":"How to build the virtual cell with artificial intelligence: Priorities and opportunities","volume":"187","author":"Bunne","year":"2024","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): A randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/13524585231224702","article-title":"Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis","volume":"30","author":"Nakamura","year":"2024","journal-title":"Mult. Scler."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.stem.2024.08.002","article-title":"Patient iPSC models reveal glia-intrinsic phenotypes in multiple sclerosis","volume":"31","author":"Clayton","year":"2024","journal-title":"Cell Stem Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tips.2023.04.005","article-title":"Artificial intelligence-driven drug development against autoimmune diseases","volume":"44","author":"Moingeon","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.fmre.2024.04.021","article-title":"Role of artificial intelligence in revolutionizing drug discovery","volume":"5","author":"Rehman","year":"2024","journal-title":"Fundam. Res."},{"key":"ref_56","unstructured":"Hamitouche, D., Ding, Y., Rajabli, R., Garcia, A.M., Thebault, S., Zhou, S., Zimianiti, I., Jacobs, B.M., Falet, J., and Collins, D. (2026, January 5\u20137). Multimodal aging signatures identify pre-diagnostic brain aging and proteomic biomarkers in MS. Proceedings of the ACTRIMS Forum, San Diego, CA, USA."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e214678","DOI":"10.1212\/WNL.0000000000214678","article-title":"Association of changes in activity patterns with brain atrophy and disability progression in people with multiple sclerosis","volume":"106","author":"Block","year":"2026","journal-title":"Neurology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12984-025-01748-z","article-title":"Integrating big data and artificial intelligence to predict progression in multiple sclerosis: Challenges and the path forward","volume":"22","author":"Khan","year":"2025","journal-title":"J. Neuroeng. Rehabil."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40708-022-00183-3","article-title":"Harnessing the potential of machine learning and artificial intelligence for dementia research","volume":"10","author":"Ranson","year":"2023","journal-title":"Brain Inform."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e00602","DOI":"10.1016\/j.neurot.2025.e00602","article-title":"Beyond relapses: How BTK inhibitors are shaping the future of progressive MS treatment","volume":"22","author":"Naydovich","year":"2025","journal-title":"Neurotherapeutics"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa2415988","article-title":"Tolebrutinib in nonrelapsing secondary progressive multiple sclerosis","volume":"392","author":"Fox","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa2415985","article-title":"Tolebrutinib versus teriflunomide in relapsing multiple sclerosis","volume":"392","author":"Oh","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1901981","article-title":"Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis","volume":"380","author":"Montalban","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-3-030-85292-4_2","article-title":"Foundations of machine learning-based clinical prediction modeling: Part I\u2014Introduction and general principles","volume":"134","author":"Kernbach","year":"2022","journal-title":"Acta Neurochir. Suppl."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5334\/egems.287","article-title":"Machine learning in health care: A critical appraisal of challenges and opportunities","volume":"7","author":"Sendak","year":"2019","journal-title":"EGEMS"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Helme, A., Kalra, D., Brichetto, G., Peryer, G., Vermersch, P., Weiland, H., White, A., and Zaratin, P. (2025). Artificial intelligence and science of patient input: A perspective from people with multiple sclerosis. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1487709"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e200116","DOI":"10.1212\/NE9.0000000000200116","article-title":"Opportunities and challenges for incorporating artificial intelligence and natural language processing in neurology education","volume":"3","author":"Sandrone","year":"2024","journal-title":"Neurol. Educ."}],"container-title":["Pathophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1873-149X\/33\/2\/35\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:38:29Z","timestamp":1779889109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1873-149X\/33\/2\/35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["pathophysiology33020035"],"URL":"https:\/\/doi.org\/10.3390\/pathophysiology33020035","relation":{},"ISSN":["1873-149X"],"issn-type":[{"value":"1873-149X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}